Program
Timetable
Brief Program
Symposium
Symposium 2Friday, March 22, 2024, 12:50～14:20
Symposium for Umbilical Cord Blood Transplantation
- Chairs
- Shuichi Taniguchi
- (Department of Hematology, Hamanomachi Hospital)
- Satoshi Takahashi
- (Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo)
Evolution of Umbilical Cord Blood As A Source of Lympho-Hematopoietic Cells – U.S. Perspective
- Presenters
- John E. Wagner
- (University of Minnesota)
Cord Blood Transplantation in China
- Kaiyan Liu
- (Peking University People's Hospital / Beijing Lu Daopei Hematology Hospital)
Umbilical cord blood transplantation as immune therapy
- Naoyuki Uchida
- (Department of Hematology, Toranomon Hospital)
A recent update on cord blood transplantation in Japan
- Takaaki Konuma
- (Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo)
Symposium 3Friday, March 22, 2024, 14:30～15:30
Haplo-HSCT: Recent changes
- Chairs
- Naoyuki Uchida
- (Department of Hematology, Toranomon Hospital)
HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide
- Presenters
- Junichi Sugita
- (Department of Hematology, Sapporo Hokuyu Hospital)
The transplant activity of older patients in China
- Xiao-Jun Huang
- (National Clinical Research Center for Hematologic Disease, Peking University People's Hospital & Institute of Hematology)
Symposium 6Friday, March 22, 2024, 14:40～16:10
Current Status of CAR-T Cell Therapy
- Chairs
- Koji Izutsu
- (Department of Hematology, National Cancer Center Hospital)
- Go Yamamoto
- (Department of Hematology, Toranomon Hospital)
Car-T therapy for lymphoma in Japan
- Presenters
- Go Yamamoto
- (Department of Hematology, Toranomon Hospital)
Management of Complications of CART
- Olalekan O. Oluwole
- (Department of Medicine, Vanderbilt University Medical Center)
CAR T-cell therapy in multiple myeloma: current status in Japan
- Satoshi Yoshihara
- (Department of Respiratory Medicine and Hematology)
Curing Multiple Myeloma with CAR T Approaches
- Krina K. Patel
- (Lymphoma/Myeloma Department, The University of Texas MD Anderson Cancer Center)
Symposium 13Saturday, March 23, 2024, 9:05～11:05
Industry-Academia-Government Collaboration Program for Cell Therapy
- Chairs
- Koji Kato
- (Department of Medicine and Biosystemic Sciences, Faculty of Medicine, Kyushu University)
- Yoshiko Atsuta
- (Japanese Data Center for Hematopoietic Cell Transplantation)
GoCART coalition initiatives on Cellular Therapies
- Presenters
- Jurgen Kuball
- (Department of Hematology, University Medical Center Utrecht, Utrecht University / on behalf of LRAC, CTWIP of EBMT and GoCART coalition)
CAR-T Therapy: The State of Out-of-Specification (OOS) Products and Future Exit Strategies
- Takahiro Kamiya
- (Clinical Research Center, Tokyo Medical and Dental University)
The real-world problems of CAR T-cell therapy: vein-to-vein intervals and unused apheresis products
- Yu Yagi
- (Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.)
The Role of Industry in Commercializing CAR-T Cell Therapy: Delivering Products to Patients
- Yoshie Tsurumaki
- (Hematology Medical Franchise, Medical Affairs Divison, Novartis Pharma K.K.)
JSTCT-KSBMT Joint SymposiumFriday, March 22, 2024, 13:00～14:30
Strategies for recurrence prevention in high-risk transplantation
- Chairs
- Seong Kyu Park
- (Soonchunhyang University Bucheon Hospital)
- Takanori Teshima
- (Department of Hematology, Hokkaido University)
Advancements in transplantation for high-risk patients with multiple myeloma
- Presenters
- Ho Sup Lee
- (Department of Internal Medicine, Kosin University College of Medicine)
Strategies for recurrence prevention in high-risk transplantation in adult patients with ALL
- Jae-Ho Yoon
- (Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
The challenge of cord blood transplantation and maintenance therapy for high-risk leukemia
- Aya Nishida
- (Department of Hematology, Toranomon Hospital)
Tyrosine Kinase Inhibitors after Allogeneic HCT for Philadelphia Chromosome-positive Leukemia
- Hideki Nakasone
- (Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University)
Luncheon Seminar
Luncheon Seminar 3Friday, March 22, 2024, 11:20～12:10
Umbilical cord blood transplant, management of GVHD
Co-sponsored by Chugai Pharmaceutical Co., Ltd.
Luncheon Seminar 14Saturday, March 23, 2024, 11:25～12:15
Ruxolitinib for chonic GVHD
Co-sponsored by Novartis Pharma K.K.
Luncheon Seminar 17Saturday, March 23, 2024, 11:25～12:15
Expert Guidance on Therapeutic Strategies for Relapsed/Refractory Myeloma (tentative)
Co-sponsored by Bristol-Myers Squibb K.K.
Luncheon Seminar 18Saturday, March 23, 2024, 11:25～12:15
The importance of anti CD38 therapy in upfront treatment for Multiple Myeloma.
Co-sponsored by Janssen Pharmaceutical K.K.
Luncheon Seminar 19Saturday, March 23, 2024, 11:25～12:15
CAR T treatment up to date - efficacy and safety management –
Co-sponsored by Gilead Sciences
Sweets Seminar
Sweets Seminar 9Friday, March 22, 2024, 16:25～17:15
Transplant positioning in B-ALL treatment strategy
Co-sponsored by Amgen K.K/Astellas Pharma Inc.
Sweets Seminar 11Friday, March 22, 2024, 16:25～17:15
License to Drive: Drifting through the curves of CAR-T therapy in Large B-cell Lymphoma
Co-sponsored by Bristol-Myers Squibb K.K.
Breakfast Seminar
Breakfast Seminar 1Saturday, March 23, 2024, 8:00～8:50
Acute leukemia cellular heterogeneity and treatment resistance
Co-sponsored by Pfizer Japan Inc.